Bath & Body Works, Inc. $BBWI Shares Bought by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lifted its stake in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 5.6% in the second quarter, Holdings Channel reports. The institutional investor owned 136,964 shares of the company’s stock after buying an additional 7,243 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Bath & Body Works were worth $4,103,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. AQR Capital Management LLC boosted its stake in Bath & Body Works by 267.8% during the 1st quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock valued at $121,073,000 after acquiring an additional 2,907,506 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in shares of Bath & Body Works by 115.7% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock valued at $111,581,000 after purchasing an additional 1,973,679 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its stake in shares of Bath & Body Works by 7.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock valued at $334,029,000 after purchasing an additional 781,681 shares in the last quarter. Nuveen LLC bought a new position in shares of Bath & Body Works during the first quarter worth about $23,273,000. Finally, Boston Partners grew its stake in Bath & Body Works by 289.7% in the first quarter. Boston Partners now owns 937,024 shares of the company’s stock worth $28,292,000 after purchasing an additional 696,555 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

Wall Street Analyst Weigh In

BBWI has been the subject of several research reports. Jefferies Financial Group decreased their target price on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating for the company in a research report on Monday, October 13th. Morgan Stanley raised their price objective on Bath & Body Works from $40.00 to $43.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. UBS Group lowered their target price on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating for the company in a research note on Friday, August 29th. Telsey Advisory Group restated an “outperform” rating and issued a $38.00 price target on shares of Bath & Body Works in a research report on Thursday. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, October 8th. Ten investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $38.18.

Read Our Latest Stock Analysis on Bath & Body Works

Bath & Body Works Stock Down 0.1%

Shares of NYSE:BBWI opened at $21.97 on Friday. The company’s 50-day moving average price is $25.50 and its 200 day moving average price is $28.55. The company has a market cap of $4.53 billion, a PE ratio of 6.52, a P/E/G ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a fifty-two week low of $21.71 and a fifty-two week high of $41.87.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.37. The company had revenue of $1.55 billion for the quarter, compared to analysts’ expectations of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business’s revenue for the quarter was down .8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, equities analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Investors of record on Friday, November 21st will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date is Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is currently 23.74%.

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Read More

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.